AxoGen OTCBB: AXGN is a leading regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions. AxoGen s products offer a full suite of surgical nerve reconstruction solutions including Avance Nerve Graft, the only commercially available processed nerve allograft for bridging severed nerves, AxoGuard Nerve Connector, a coaptation aid allowing for close approximation of severed nerves, and AxoGuard Nerve Protector, a bioscaffold used to reinforce a coaptation site, wrap a partially severed nerve or isolate and protect nerve tissue.
Quote | Axogen Inc. (NASDAQ:AXGN)
Last: | $7.66 |
---|---|
Change Percent: | 0.0% |
Open: | $7.55 |
Close: | $7.66 |
High: | $7.66 |
Low: | $7.23 |
Volume: | 320,989 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Axogen Inc. (NASDAQ:AXGN)
2024-07-01 07:30:05 ET Raymond James analyst issues OUTPERFORM recommendation for AXGN on July 1, 2024 05:51AM ET. AXGN was trading at $7.24 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations
ALACHUA, Fla. and TAMPA, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced making an inducement grant on July 1, 2024, under NASDAQ listing rule 5635(c)(4) in conn...
Message Board Posts | Axogen Inc. (NASDAQ:AXGN)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $AXGN News Article - Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Re | whytestocks | investorshangout | 03/14/2023 3:00:59 PM |
whytestocks: $AXGN News Article - Axogen Announces Independent Publication of Comparative Nerve Gap | whytestocks | investorshangout | 01/05/2023 4:15:48 PM |
whytestocks: $AXGN News Article - Axogen to Participate in the 76th Annual Meeting of the American S | whytestocks | investorshangout | 09/22/2021 6:45:50 PM |
whytestocks: $AXGN News Article - Axogen, Inc. to Present at the Canaccord Genuity Musculoskeletal C | whytestocks | investorshangout | 05/06/2021 5:45:48 PM |
$AXGN waking up on strong fins and projections | Prudent Capitalist | investorshub | 02/19/2021 9:33:52 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-01 07:30:05 ET Raymond James analyst issues OUTPERFORM recommendation for AXGN on July 1, 2024 05:51AM ET. AXGN was trading at $7.24 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations
ALACHUA, Fla. and TAMPA, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced making an inducement grant on July 1, 2024, under NASDAQ listing rule 5635(c)(4) in conn...
ALACHUA, Fla. and TAMPA, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the launch of its newest product, Avive+ Soft Tissue Matrix™. Avive+™ ...